RARA CRAFT DATABASE for FDA Medical Devices
510(k)K261481

FDA DEVICE FACTS

Pangea Femur Reconstruction System

Stryker GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 29, 2026PRODUCT CODEHSB

Indications for use

The Pangea Femur Reconstruction System is indicated for the internal fixation and stabilization of femur bone fractures and osteotomies in normal and osteopenic bone, including:

• Diaphyseal, metaphyseal, epiphyseal, extra- and intra-articular fractures.

• Non-unions, malunions, and deformities.

• Periprosthetic fractures. Additionally, the Trochanter Plates and Trochanter Attachment Plate are indicated for use in the fixation of the greater trochanter due to trochanteric fracture or osteotomy. When used with the T2 Alpha Femur Retrograde Nailing System, The Pangea Femur Reconstruction System is used for the indications of the T2 Alpha Femur Retrograde Nailing System.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026